VivoSim Labs, Inc. Common Stock
VIVS • NASDAQ
VivoSim Labs, Inc. Common Stock is a biological products, (no disgnostic substances) company trading on NASDAQ, led by CEO Keith E. Murphy, with a market cap of $4.2M.
CEOKeith E. Murphy
Next Earnings
Upcoming earnings announcement for VivoSim Labs, Inc. Common Stock
Date
Thursday, June 4, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q4 2026
Earnings History
Past 11 earnings reports for VivoSim Labs, Inc. Common Stock
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 6, 2025 | Q2 2026 | -$0.98 | — | $28.0K | — |  10-Q |
| Aug 12, 2025 | Q1 2026 | -$1.14 | — | $37.0K | — | 10-Q |
| Feb 19, 2025 | Q3 2025 | -$2.28Est: -$2.52 | +9.5% | $24.0KEst: $40.0K | -40.0% | 10-Q |
| Nov 8, 2024 | Q2 2025 | -$1.68Est: -$3.12 | +46.2% | $30.0KEst: $40.0K | -25.0% | 10-Q |
| Aug 5, 2024 | Q1 2025 | -$2.76Est: $0.00 | — | $39.0KEst: $50.0K | -22.0% | 10-Q |
| May 31, 2024 | Q4 2024 | -$3.48Est: -$5.04 | +31.0% | $29.0KEst: $75.0M | -100.0% | 10-K/A |
| Feb 8, 2024 | Q3 2024 | -$4.80Est: -$6.00 | +20.0% | $5.0KEst: $120.0M | -100.0% | 10-Q |
| Nov 9, 2023 | Q2 2024 | -$5.52Est: -$5.16 | -7.0% | -Est: $80.0K | -100.0% | — |
| Aug 10, 2023 | Q1 2024 | -$5.52 | — | $75.0K | — | — |
| Jul 14, 2023 | Q4 2023 | -$10.20 | — | $162.0K | — | — |
| Feb 9, 2023 | Q3 2023 | -$4.44 | — | $131.0K | — | — |